CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Making Genetics has developed a blood test and algorithm to predict the severity of rheumatoid arthritis. This personalized approach aims to improve treatment outcomes by identifying patients who require more aggressive therapies.
Rheumatoid arthritis (RA) affects 1% of world population (17.6 M) and it is a relevant economic burden (€45 Bn spent yearly in Europe).
It is a degenerative disease that affects bone health, cause joints’ deformity, impact other organs and cause disability.
An early and personalized treatment can greatly improve its outcome, achieve remission and reduce pain, thus an accurate prognosis is critical for its efficient management.
However, this is difficult for the lack of good prognosis factors (cu…
MAKING GENETICS S.L.
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
